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Mononuclear,  non-heme-Fe(II)  centers  are  key structures  in  O2 metabolism  and catalyze  an  impres-
sive  variety  of enzymatic  reactions.  While  most  are  bound  via  two  histidines  and  a carboxylate,  some
show  a different  organization.  A  short  overview  of  atypically  coordinated  O2 dependent  mononuclear-
non-heme-Fe(II)  centers  is  presented  here  Enzymes  with  2-His,  3-His,  3-His-carboxylate  and  4-His
bound  Fe(II) centers  are  discussed  with  a focus  on their reactivity,  metal  ion  promiscuity  and
Abbreviations: 1,3-bis(2-pyridylimino)isoindoline, ind; 2OH-1,3-Ph2PD, 2-hydroxy-1,3-diphenylpropanedione; 6-Ph2TPA, N,N-bis[(6-phenyl-2-pyridyl)methyl]-N-
(2-pyridyl)-methyl]amine; -KG, -ketoglutarate; acac, acetylacetone (2,4-pentanedione); ADO, cysteamine dioxygenase; AO, apocarotenoid 15,15′-oxygenase; ARD,
ci-reductone  dioxygenase; BsQDO, quercetin 2,3-dioxygenase from Bacillus subtilis; CarOs, carotenoid oxygenases; CD, circular dichroism; CDO, cysteine dioxygenase;
GDO,  5-chloro-gentisate 1,2-dioxygenase; CS2, clavaminate synthase; DFT, density functional theory; Dke1, diketone dioxygenase; EPR, electron paramagnetic reso-
ance;  EXAFS, extended X-ray absorption ﬁne structure spectroscopy; ﬂa, ﬂavonolate; GDO, gentisate 1,2-dioxygenase; HADO, 3-hydroxyanthranilate 3,4-dioxygenase;
GDO, homogentisate 1,2-dioxygenase; HNDO, hydroxy-2-naphthoate dioxygenase; MCD, magnetic circular dichroism; MNHEs, mononuclear non-heme-Fe(II) dependent
nzymes;  NRP, nonribosomal peptide; OTf-, triﬂuormethanesulfonate; PDB, protein data bank; QDO, quercetin 2,3-dioxygenase; SDO, salicylate 1,2-dioxygenase; TauD,
aurine  hydroxylase; XAS, X-ray absorption spectroscopy.
∗ Corresponding author.
E-mail  address: grit.straganz@tugraz.at (G.D. Straganz).
1 This review focuses on mononuclear non-heme iron enzymes that utilize O2 as a co-substrate. Furthermore, it is restricted to enzymes that use Fe(II) in the resting form
f  the catalytically competent enzyme. Consequently, lipoxygenases, which show a distinct metal center geometry and depend on the activation of the primary Fe(II) center
o  Fe(III), which is then the catalytically competent – substrate activating – form of the active site, are not discussed.
010-8545 ©  2012 Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.ccr.2012.04.028
Open access under CC BY license.
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recent  progress  in  the  elucidation  of  their enzymatic  mechanisms.  Observations  concerning  these  and
classically coordinated  Fe(II)  centers  are  used  to  understand  the  impact  of the  metal  binding  motif  on
catalysis.
© 2012 Elsevier B.V. 
1
d
d
i
C
t
g
r
s
O
t
a
e
a

c
M
t
c
o
s
Open access under CC BY license.tructure–function relationships
. Introduction—mononuclear non-heme-Fe(II) and O2
ependent enzymes (MNHEs)1
MNHEs are key-players in O2 metabolism, on which aerobic life
epends. The catalytic diversity of MNHEs, which comprises chem-
cally challenging reactions such as hydroxylation, desaturation,
 C bond breakage and ring closure, parallels and complements
he versatility of the heme containing P450 enzymes [1,2]. MNHEs
enerally bind and activate O2 directly at the Fe(II) center and the
esulting iron oxygen intermediates react with the organic sub-
trate(s) to form the products. As the one-electron reduction of
2 at the iron center is thermodynamically unfavorable [3], addi-
ional electron sources are generally required to promote dioxygen
ctivation [4]. MNHEs can be grouped according to the respective
lectron-source into ‘self sufﬁcient’ cofactor independent enzymes
nd O2 activating enzymes that depend on cofactors such as pterin,
-ketoglutarate (-KG), ascorbate or an electron providing Rieske
luster [1,2,5]. Examples of typical reactions that are catalyzed by
NHEs are summarized in Fig. 1.
MNHEs generally share a common metal binding motif, termedhe 2-His-1-carboxylate ‘facial’ triad, where two histidine and one
arboxylate-containing side chain are arranged at one face of an
ctahedron [6–8]. The other three coordination positions provide
ites for O2 and the organic substrate(s) or – in the enzyme’s
Fig. 1. Prototypical reactions of MNHEs that show the 2-Hresting state – water  ligands. This general arrangement is believed
to allow for an efﬁcient coupling of dioxygen activation and
substrate oxidation with water ligands protecting the metal center
from auto-oxidation and uncoupled cofactor oxidation (Fig. 2
A). Only when all required co-substrates (B) and substrates are
bound to the active site is a coordination site vacated, due to steric
interactions and/or donor-effects of the chelating (co)substrate,
(C) and O2 can bind to Fe(II) (D) [9,2].
2. Atypically coordinated mononuclear non-heme-Fe(II)
centers
Rather recently, a handful of O2 dependent MNHEs with distinct
reactivities and metal binding motifs have been reported, raising
the questions of why most MNHEs have the facial triad and what
function is associated with the unconventional metal centers. A
deeper understanding of the structural role of the metal center in
MNHEs is important to fully exploit the synthetic potential of the
MNHE catalytic center in the design of new functions. ‘Atypical’
non-heme-Fe(II) binding sites coordinate the metal center by (i)is-1-carboxylate ‘facial triad’ Fe(II)-binding motif.
two histidine-, (ii) three histidine-, (iii) three histidine- and one
carboxylate- and (iv) four histidine-side chains. Interestingly, with
the exception of the 4-His binding motif, the atypically coordi-
nated non-heme-Fe(II) centers are generally found in proteins that
D. Buongiorno, G.D. Straganz / Coordination Chemistry Reviews 257 (2013) 541– 563 543
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vig. 2. Mechanistic paradigm for dioxygen activation at the 2-His-1-carboxylate 
eacetoxycephalosporin C synthase (PDB: 1RXF).
he  Figure is adapted from Costas et al. [2].
how a cupin-(-barrel) fold. The prototypical cupin metal binding
otif [10] is shown in Fig. 3, along with typically and atypically
oordinated MNHEs that show a cupin fold.
In the following we summarize work done on the mechanisms of
nzymes with atypically coordinated non-heme-Fe(II) centers and
iscuss how these structural variations impact catalysis in relation
o facial triad MNHEs.
.1.  The 2-His motif–mononuclear non-heme-Fe(II) halogenases
.1.1.  Physiological function
Mononuclear non-heme iron and -KG dependent halogenases
ere ﬁrst reported from the laboratory of Walsh [11,12]. Others
ave been characterized since in vitro [12–14,11,15–17] and more
ave been identiﬁed by correlation of natural product structure and
enetic and bio-informatic analyses [18,19]. All of these enzymes
tudied to date are found in biosynthetic pathways of nonriboso-
al peptides (NRPs), natural metabolites with often remarkable
io-activities. The enzymes are part of an assembly line and halo-
enate NRP building blocks, e.g. amino acids [11], fatty acids [18]
nd even piperazine [15], which are then incorporated into the
RP structure. Halogenation by a 2-His coordinated Fe(II) center
s also employed in order to synthesize cyclopropyl-containing
mino-acids  in NRP biosynthesis, where a non-oxidative, C-C bond
ormation and concomitant expulsion of the Cl− moiety by a
avin-cofactor containing enzyme or MNHE have been reported
o complete cyclopropane formation [12,17].
.1.2. General mechanism–the role of the 2-His binding motif
The  enzymes characterized so far do not act on free substrates,ut on substrate moieties which are covalently linked to a carrier-
rotein via a phosphopantetheinyl arm. Fig. 4 depicts the halo-
enations of a coupled threonine by the Fe(II) and -KG dependent
alogenase SyrB2 in the biosynthetic pathway of syringomycin E.
ig. 3. Conserved metal binding motif in cupins. (a.) An alignment of O2 dependent cupins
ed  (carboxylate), moieties in ‘conserved’ positions are in bold. Variable residues in the cu
TauD), SyrB2, cysteine dioxygenase (CDO), diketone dioxygenase (Dke1), gentisate dioxy
-hydroxyanthranilate3,4-dioxygenase (HADO) and homogentisate dioxygenase (HGDO
rototypical metal center organization of a cupin-metal center is shown. (For interpretat
ersion of the article.) triad MNHEs as proposed by Solomon [1,9] as exempliﬁed by the active site of
Sequence similarity and cofactor dependence have suggested
early on that the -KG dependent halogenases follow a similar
mechanism as -KG dependent dioxygenases, where the oxygena-
tive decarboxylation of the cofactor and subsequent homolytic
O O cleavage yield an Fe(IV) O intermediate. This highly reactive
electrophilic agent will then abstract a hydrogen atom from the
substrate, and the resulting radical will react with a metal bound
halide ion [11]. It was unclear how chloride could coordinate to
the metal ion subsequent to dioxygen activation and formation of
a very reactive Fe(IV) O species, however. The crystal structure of
the halogenase SyrB2 that was solved by Blasiak and co-workers
showed how that dilemma is solved. The structure revealed a devi-
ation from the prototypical ‘facial triad’, where a Cl− binding pocket
is provided in place of the carboxylate moiety, resulting in a 2-His-
Fe(II) site for metal coordination [21]. The Fe(II) containing protein
structure was crystallized in the presence of -KG. So far no metal
containing crystal structure of a halogenase has been solved in the
absence of -KG and it has been suggested that Fe(II) is labile in the
absence of the cofactor. Fig. 5 shows the active site of the haloge-
nase SyrB2. The proposed chemical mechanism of the halogenating
2-His metal center is depicted in Fig. 6.
2.1.3. Metal-center and active-site geometry
Magnetic circular dichroism (MCD) spectroscopy on CytC3,
which catalyzes the double chlorination of L-2-aminobutyric acid,
reveals that the 2-His-Fe(II) binding site shows weak afﬁnity for
Fe(II) compared to the facial triad with an additional carboxylate;
The metal will only bind in the presence of -KG as an additional
ligand [22]. The Fe(II) center of CytC3 in the presence of Cl− and
-KG is distorted six coordinate, however contrary to the facial
triad enzyme clavaminate synthase (CS2) the 6th ligand, a water
molecule, is only weakly bound. It has been argued that the car-
boxylate residue in the facial triad serves to stabilize the water
ligand [23] as found in the crystal structure of resting CS2 [24].
 that use Fe(II) as a cofactor is displayed. Metal binding residues are in blue (His) and
pin motif are in light grey. Abbreviations indicate the MNHEs taurine hydroxylase
genase (GDO), quercetin 2,3-dioxygenase (QDO), aci-reductone dioxygenase (ARD),
). The respective protein data bank (PDB) numbers are given in brackets. (b.) The
ion of the references to color in this ﬁgure legend, the reader is referred to the web
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o  the peptidyl-carrier protein domain (T) in the two-domain protein SyrB1 via a ph
dapted from Vaillancourt [20].
he role of the carboxylate, however, does not appear to be a gen-
ral feature of facial triad enzymes. Taurine hydroxylase (TauD)
lso shows a weak water ligand in complex with -KG [22] and
he crystal structure displays the carboxylate moiety in an orienta-
ion where the non-coordinating oxygen of the carboxylate ligand
s ﬂipped down and away from the open (i.e. water) coordina-
ion site and will therefore not partake in the stabilization of the
ater ligand [25,26]. Apparently, other structural features play an
dditional role in maintaining hexa-coordination and thus prevent
ncoupled reactivity. It has been suggested based on CS2 and TauD
rystal structures that the strong versus weak water binding corre-
ates with the closeness of bound substrate to the metal center and,
onsequently, to how efﬁciently the substrate can displace the 6th
igand in order to make the center reactive for O2. No structural data
or halogenases with substrate bound are available but a signiﬁcant
umber of 6-coordinate species are found via MCD  spectroscopy
ig. 5. Metal binding center of SyrB2 in the presence of chloride and -KG (PDB:
FCT)  showing six-coordinate geometry. Fe(II) is shown in orange, the chloride anion
s depicted in green, water molecules are in slate blue. Oxygen and nitrogen atoms
re shown in red and blue. (For interpretation of the references to color in this ﬁgure
egend, the reader is referred to the web  version of the article.) biosynthetic pathway of the NRP syringomycin E. The threonyl moiety is tethered
pantetheinly arm. Holo-SyrB1 is then used as a substrate for the halogenase SyrB2.
suggesting that the bound substrate does not efﬁciently destabi-
lize hexacoordination [22]. Thus the weak 6th ligand in CytC3 may
serve the purpose to facilitate formation of the 5-coordinate center,
in analogy to the mechanism of O2 activation in facial triad enzymes
(Fig. 2).
The  crystal structure of CytC3 has been solved in its open form
where it shows low afﬁnity for -KG (50%) and no chloride is
present n the crystal structure despite its presence during crystal-
lization. This is in contrast to the crystal structure of SyrB2 where
it has been suggested that a hydrophobic pocket and H-bonding
together stabilize Cl− binding in the active complex [27]. Crystal
structures of the halogenase domain of CurA, which catalyzes the
cryptic chlorination leading to cyclopropane ring formation in the
synthesis of the natural product curacin A, have been solved in open
and closed forms. A switch from the open to the closed mode appar-
ently occurs upon -KG binding [28]. These observations imply that
major structural rearrangements are required for the halogenase
metal center in order to adopt its fully active form.
Matthews and coworkers have determined that the native
substrate of SyrB2 accelerates the reaction with O2 8000-fold,
compared to the phosphopantetheinlyated substrate carrier pro-
tein without covalently linked threonine. It was also demonstrated
that chloroferryl formation in SyrB2 is 5–24-fold less efﬁcient
when other amino-acids are tethered to the substrate carrier
protein SyrB1. With the alternative carrier protein CytC2, threonyl
conversion was  40-fold slower compared to SyrB1, but the reac-
tivity depended on the concentration and therefore, this effect is
probably at least in part due to a lower afﬁnity of the carrier pro-
tein to the halogenase [29]. However, reactivity with O2 could be
induced in principle. As for alternative substrates, it was found that
stable chloro-ferryl species could be generated with substrates
that lacked a hydrogen atom at an abstractable, C-4, position.
The resulting stable chloroferryl species was characterized via
extended X-ray absorption ﬁne structure (EXAFS) spectroscopy.
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ata analyses resulted in a best ﬁt for the Fe(IV) center that included
 shells of scatters, namely one Cl− ligand at 2.31 A˚, a short O/N lig-
nd at 1.64 A˚ and three O/N ligands at 2.12 A˚. These results were in
greement with density functional theory (DFT) calculations [29].
.1.4.  Hydroxylation versus halogenation in mononulcear
on-heme-Fe(II) dependent halogenases
Given that no measurable amounts of hydroxylated products
ave been detected in halogenase reactions [11,21] an intriguing
uestion was, how do the enzymes ensure halogenation versus
ydroxylation in the rebound step of the mechanism (Fig. 6, last
tep of the reaction cycle). Five major hypotheses have been pro-
osed: (i) Halogen-radical rebound is considered the favored route
ased on reduction potentials [30]. This suggestion was backed
y studies of a selectively chlorinating inorganic complex [31]. In
ne study computational analyses using DFT calculations on the
rst shell residues of the halogenase active site have also shown
hat halogenation is energetically more favorable than hydroxy-
ation [32]. In contrast Pandian and co-workers ﬁnd comparable
nergies, but suggest that outer shell residues and a change in the
rotonation state may  lead to a preference for halogenation [33].
owever, mutational analysis of SyrB2 demonstrated that a recon-
titution of the facial triad by mutation of the alanine residue to
spartate or glutamate did not yield hydroxylase activity, but halo-
enase activity was abolished [21]. This result refutes the idea that
edox-potential is the overriding reason for preferred halogenation.
ii) Based on two rapidly inter-converting ferryl-species detected
ia Mössbauer spectroscopy [30] analogous dynamics regarding
he Cl–Fe–OH rebound species have been suggested to bring about
referred halogen radical rebound. Notably only a single ferryl-
pecies is observed in hydroxylases [34–38]. Other suggestions
ased on computational studies have been (iii) that protonation of
he metal cofactor bound OH− may  occur, thus impeding hydroxyls proposed in analogy to the mechanisms of -KG dependent dioxygenases [21].
rebound  [33]. (iv) Alternatively, it has been proposed that CO2,
which evolves from the -KG cofactor after decarboxylation, may
carry away the OH− species as a bicarbonate so that only the
halogen species is left for rebound [39]. (v) Based on the haloge-
nase crystal structure it has been argued that substrate positioning
determines the preference for halogenations [21]. Matthews and
coworkers (vide supra) could show that chloroferryl formation in
SyrB2 dependent on the substrate structure with some substrates
actually giving accelerated rates of Fe(IV) O decay compared to
the native substrate and it was suggested that this may  correlate
with substrate vicinity [29]. A subsequent study used fast kinetic
and product analyses on a range of deuterated and non-deuterated
substrate analogues. Norvaline, which has a chain length increased
by one carbon atom compared to threonine, exhibited an up to
130-fold faster ferryl-decay. This acceleration apparently correlates
with a target C H bond in the norvaline structure that comes closer
to the H-abstracting ferryl species than the analogous C H bond in
threonine [40]. Intriguingly the faster H-abstraction rate came at
the expense of an increase in hydroxylation products. These obser-
vations imply that halogenases position the target sites away from
the H-abstracting Fe(IV) O species in order to prevent competing
hydroxylation, and this comes at the cost of lower H-abstraction
rates by the ferryl-species. Summarizing, these results strongly
suggest that the overriding reason for halogenations in SyrB2 is
substrate positioning.
2.1.5.  Biomimetic complexes
Friese  and coworkers synthesized biomimetic complexes that
model -ketoglutarate coordinated halogenase active sites using
bulky -keto-acids as ligands. Two  of these complexes were
crystallized, which show a pentacoordinate Fe(II) center. Two
coordination sites are occupied by nitrogen atoms of the respec-
tive chelate ligand, namely N,N,N′,N′-tetramethylpropylendiamine
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sig. 7. Bioinorganic complexes of Fe(II) with chloride, the bulky -keto-acid 2,6
imethyl-2,2′-bipyridine mimick the active site geometry of cofactor bound Fe(II)
enzoyl formate is used and the chloride ion cannot be stabilized at the Fe(II) cente
Fig. 7A) or 6,6′-dimethyl-2,2′-bipyridine (Fig. 7B). The other
oordination sites are occupied by the oxygen atoms of the biden-
ately coordinated -keto-acid 2,6-dimesitylbenzoyl formate
nd a chloride atom. The metal center geometries are distorted
quare pyramidal. Over all the complexes showed a geometry that
imicked the halogenase active site quite well. However, bulky
ubstituents at the -keto-acid were required in order to stabilize
he iron-chloride bond. A 6,6′-dimethyl-2,2′-bipyridine complex
hat was synthesized using the unsubstituted benzoyl formate
igand led to an octahedral complex of the chelate ligand and
wo bidentately bound -keto-acids (Fig. 7C) and no coordinated
hloride ion. While this complex readily decarboxylated in the
resence of O2, the structural halogenase mimics were inert. It was
rgued, that the steric bulk in the complexes lead to an encapsu-
ation of the -ketocarboxylate group which became inaccessible
o attack by a putative reactive dioxygen species. These results
emonstrate how carefully halogenases need to tune their metal
enter structures, in order to be catalytically competent [41].
.2.  The 3-His motif
.2.1.  Cysteine dioxygenase (CDO) and thiol oxygenating enzymes
.2.1.1. Physiological role. CDO catalyzes the ﬁrst committed step
n cysteine catabolism in mammals, where it oxygenates cysteine
o cysteine sulﬁnic acid, which can then be decarboxylated to
ypotaurine or transaminated to 3-sulﬁnylpyruvate that is spon-
aneously further converted to pyruvate and sulﬁte [42–44]. Four
ifferent CDOs from Bacillus and Streptomyces strains have been
dentiﬁed based on bio-informatic searches and their competence
o oxidize cysteine with similar catalytic activity as rat CDO has
een demonstrated [45]. Bacterial CDOs show low overall similarity
ith eukaryotic CDO (12–21% identity with rat CDO) but have a con-
erved 3-His metal binding site, according to sequence alignments.
Current data and sequence alignments suggest that the
-His-Fe(II) center found in CDO is a common feature of thiol-
ioxygenases [46], of which two more are known so far: (i)
ysteamine dioxygenase (ADO) converts cysteamine – a compound
hich is released during coenzyme A degradation – to hypotau-
ine in a reaction that is analogous to CDO catalysis. CDO and
DO have important metabolic roles in mammalian metabolism.
ogether, CDO and ADO remove thiol compounds, produce taurine
nd hypotaurine and produce inorganic sulfur. ADO was identi-
ed based on bio-informatic genome analyses. Two  open reading
rames in the mouse genome show rather low similarity to the CDO
equence but have the key cupin metal binding motif rather wellsitylbenzoyl formate and (A) N,N,N′ ,N′-tetramethylpropylendiamine or (B) 6,6′-
ndent halogenases but are inert towards O2. (C) A complex, where unsubstituted
s -ketoacid decarboxylation in the presence of O2.
conserved.  Biochemical analyses revealed that the two hypotheti-
cal paralogs of CDO indeed accept cystamine but not cysteine as a
substrate [45]. (ii) Bruland and coworkers have recently identiﬁed
two bacterial homologues of CDO from Variovorax paradoxus TBEA6
and Ralstonia eutropha H16. These enzymes catalyze the oxidation
of 3-mercaptopropionate to sulﬁnopropionate but do not convert
cysteine and cysteamine [47]. Both enzymes show strong similar-
ity to bacterial CDOs, based on the motif deﬁned by Dominy and
co-workers [45].
2.2.1.2.  Metal-center and active-site geometry. Electron paramag-
netic resonance (EPR) spectroscopic studies have shown that the
afﬁnity of the Fe(II) center to the O2 mimic  NO is strongly increased
in the presence of substrate [48] demonstrating the ‘activation’ of
the metal center for O2 reduction by substrate coordination. It has
been suggested that bidentate coordination of the substrate lowers
the reduction potential of Fe(II), thus priming it for the reduction of
dioxygen. Also, the presence of a water ligand in the resting enzyme
may protect Fe(II) from oxidation. Notably, the substrate analogues
cysteamine, 3-mercaptopropionate and 1-mercaptopropane did
not achieve a signiﬁcant increase in afﬁnity for NO, possibly due
to low substrate afﬁnity to the active site.
A low spin {FeNO}7 (S = 1/2) species resulted, contrary to the
typically observed high spin {FeNO}7 (S = 3/2) complexes observed
in 2-His-1-carboxylate enzymes. It was argued that this electronic
difference may  be caused by the amido-rich coordination sphere
compared to 2-His-1-carboxylate enzymes. While results from
EXAFS spectroscopy suggested that coordination of cysteine via
its carboxy-moiety was the most likely mode of coordination [49],
MCD  spectroscopy of the cysteine-coordinated complexes revealed
near UV transition bands, which were red-shifted for the seleno-
cysteine-bound analogue, supporting direct coordination of the
thiol-group to the Fe(II) cofactor. MCD  data did not deﬁne the geom-
etry of the resting active site of CDO. A visible transition of the
cysteine-coordinated Fe(III)-CDO further indicated direct coordi-
nation of cysteine to the metal cofactor [50].
Crystal structures of free eukaryotic CDOs from mouse [51] and
rat [52] have been solved and show a 3-His metal binding center
(Fig. 8A). Depending on the bound metal ion, Ni(II) [51] or Fe(III)
[52], one or three additional water ligands were found in the active
site, giving tetrahedral or octahedral coordination, respectively,
whereby the localization of the actual ligands did not signiﬁcantly
change. A structure of human CDO which was  anaerobically co-
crystallized with cysteine shows that cysteine [53] is coordinated
to the Fe(II) center via its sulfur and amino group supporting the
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Fig. 8. Active site of (A) resting CDO (PDB:2B5H), (B) L-cysteine bound CDO (PDB:2IC1) [61] and (C) persulfenate coordinated CDO (PDB:3ELN) [51]. Metal binding amino acids
and  the covalently linked outer sphere residues Cys93 and Tyr157 are shown. Note that the resting CDO structure contains an Fe(III) ion, while substrate and intermediate
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ode of substrate coordination as initially proposed by McCoy
nd coworkers (Fig. 8B) [52]. Remarkably, the crystal structures of
ukaryotic CDO revealed that cysteine Cys93 is covalently linked
o active site tyrosine Tyr157 (using rat numbering; Fig. 8). This
ysteine is prototypical for eukaryotic CDOs and replaces the glu-
amate residue that is generally found in the cupin-motif.
.2.1.3. The role of the tyrosine-cysteine crosslink in the active site.
he thioether Cys-Tyr crosslink, which is found throughout eukary-
tic CDO crystal structures has raised the question of a putative
ole as a ‘radical cofactor’ in the catalytic mechanism of cysteine
xygenation. Such cofactors have been described for galactose oxi-
ase [54], glyoxal oxidase [55,56] and a sulﬁte reductase [57]. Both
orms, CDO with and without the Cys-Tyr crosslink, are found
n tissues and cell cultures [43,58–60]. A radical scavenger could
ot signiﬁcantly reduce catalytic activity of CDO at a 1000-fold
xcess [47], supporting a scenario where catalysis does not involve
 mechanism that depends on a putative tyrosine radical as, e.g.
escribed in galactose oxidase.
It has been demonstrated that the crosslink forms under
urnover conditions, i.e. in the presence of cysteine, Fe(II) and
2, and it promotes enzyme activity [58]. Notably, the cross-link
orms slowly, after an estimated 800 turnovers. Enzymatic activity
n the absence of a crosslink is markedly reduced [43,60]. Muta-
ional analyses give a two- and ﬁve-fold decrease in activity for the
ubstitution of Cys93 by serine and a ten- and twenty-fold lower
ctivity regarding the Tyr157 to phenylalanine substitution in rat
nd human CDO, respectively [58,61]. Furthermore, the cross-link
pparently enhances catalytic stability about two-fold [58]. Ye and
o-workers have found that a reduced catalytic activity correlates
ith lower iron content in the CDO variants and have suggested that
his is the actual reason for activity loss in the variants. A lowered
fﬁnity for the Fe(II) cofactor may  impact apparent turnover num-
ers in the presence of Fe(II) in the assay, as described by Dominy
58]. A further hypothetical role, proposed by Ye and co-workers,
s that Tyr157 may  stabilize radical intermediates during catalysis
nd thus prevents the uncoupling of the reaction. Taken together,
ata support a scenario where the Tyr-Cys crosslink stabilizes the
esting iron center and possibly reaction intermediates (vide infra).
Notably, bacterial CDOs do not only show low over-all simi-
arity with eukaryotic CDOs (12–21% identity with rat CDO), but
any of them also do not have the conserved cysteine, which forms
he thioether bond to the tyrosine in the active site of eukaryotic
tructures. This, along with he fact that mutants are active and the
nzyme turns over 800 times before the crosslink is formed, sug-
ests that the thioether bond is not a crucial structural requirement
or cysteine oxygenation. The structure of a bacterial CDO has beenwater molecules are slate blue; oxygen, nitrogen and sulfur-atoms are depicted in
interpretation of the references to color in this ﬁgure legend, the reader is referred
deposited  in the Protein Data Bank (PDB). The metal center shows
octahedral geometry, and a comparison with eukaryotic structures
suggests that the Tyr-Cys crosslink in eukaryotic CDOs may  lead to
a distortion of the water-shell geometry in eukaryotic CDOs [61].
The bacterial structure so far remains unpublished (PDB: 2GM6).
2.2.1.4.  Reaction mechanism. Several reaction mechanisms have
been proposed for CDOs. Here, based on accumulated evidence that
the substrate’s sulfur atom is coordinated to the metal ion during
catalysis, three principle mechanisms are discussed that follow this
scenario. The mechanism that was  initially proposed based on the
crystal structure of resting Ni(II)-CDO (Fig. 8A) is shown in Fig. 9.
It proceeds via substrate binding and subsequent activation of O2
at the iron center, and – after oxidation of the sulfur moiety by
Fe(III) – an attack of the activated oxygen species at the sulfur.
The resulting four-membered ring then collapses, thus transferring
one oxygen onto the sulfur atom. Finally the second, metal-bound
oxygen species is also transferred to the sulfur moiety.
An  alternative mechanism has been suggested by Ye and co-
workers based on the structure of human Fe(II)-CDO in complex
with substrate (Fig. 8B) [61], where a role of the thioether bonded
Tyr157 residue has been proposed. As described in Fig. 10, cysteine
coordinates to the tetrahedrally coordinated active site as found
in the structure of resting Fe(III)-CDO from rat [53]. The resulting
ﬁve-coordinate center binds and activates O2, which then attacks
the iron-bound sulfur. The resulting four membered ring cleaves
homolytically at its O O bond, resulting in a high-valent Fe(IV)-
oxo species, which then attacks the sulfur and transfers the second
oxygen moiety. It is suggested that Tyr157 stabilizes the resting
metal center and the transition states of dioxygen activation and
Fe(IV)-oxo species formation.
A  structure of CDO with a putative persulfenate intermediate
coordinated to the Fe(II) cofactor has been solved by Simmons and
coworkers (Fig. 8C), [51]. Based on the active site organization of
this structure it has been suggested that not the iron-terminal but
the iron-proximal oxygen atom of the proposed superoxide inter-
mediate oxidizes the metal bound sulfur atom (Fig. 11).
Very  recently, Crawford and coworkers [62] have described the
catalytic turnover of cysteine by Fe(III)-CDO and superoxide. Cat-
alytic turnover rates in this chemical rescue experiment were at
least 200-fold slower than in wild type enzyme and it is there-
fore still unclear how analogous this reaction is to that of the
native enzyme. The fact that this conversion is feasible in princi-
ple, supports a mechanism that proceeds via an Fe(III)-superoxo
intermediate.
Computational analysis: Computational analyses of the reaction
mechanism via QM and QM/MM  calculations suggest a Fe(IV)
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sFig. 9. Reaction mechanism of cysteine oxidation as propo
ntermediate in the reaction cycle [63,64] similar to the mech-
nism proposed by Ye and co-workers [61]. Notably, QM/MM
alculations ﬁnd the oxygenation of sulfur by the Fe-proximal
xygen, as has been proposed based on the persulfenate contain-
ng crystal structure, to be a high energy pathway. It has been
uggested that the intermediate found in the crystal structure may
ctually reﬂect a side product of the reaction [63]..2.1.5. Biomimetic complexes. Biomimetic complexes which oxy-
enate a sulfur ligand upon reaction with O2 [65,66] have been
ynthesized recently. A bis(imino)pyridine (BIP) ligand scaffold
Fig. 10. Reaction mechanism of cysteine oxidation as proposed based on tsed on the mouse crystal structure, adapted from ref. [52].
was  employed, which contained a thiolate moiety. The resulting
Fe(II)(LN3S)(OTf) complex (Fig. 12A, left) showed distorted square
pyramidal geometry, with the triﬂuormethanesulfonate (OTf−) lig-
and occupying the axial position. The complex was reactive with
O2 and in mass spectrometric analysis a doubly oxygenated species
was observed which disappeared over time. The product complex
could not be crystallized, but based on product analysis a sul-
fonato complex was proposed as the ﬁnal product (Fig. 12A, right).
Based on 18O incorporation studies and mass spectrometry it was
shown that two atoms of molecular oxygen were initially incorpo-
rated into the sulfonate product, followed by a third insertion of
he human, substrate bound crystal structure, adapted from ref. [61].
D. Buongiorno, G.D. Straganz / Coordination Chemistry Reviews 257 (2013) 541– 563 549
F  at th
s
A
l
c
s
c
y
l
B
(
r
d
o
t
i
i
F
F
t
B
p
F
tig. 11. Reaction mechanism of CDO involving attack of the proximal oxygen atom
tructure which has a persulfenate bound to the Fe(II) center.
dapted  from ref. [51].
abeled oxygen after longer incubation times. The analogous Zn(II)
omplex was inactive. In a subsequent work, two  complexes were
ynthesized, which bind a thiolate ligand that is not a part of a
helate system. Isopropyl-BIP (iPrBIP), phenylthiol (PhSH) and Fe(II)
ielded two complexes that differed in geometry, when crystal-
ized in the presence of Cl− or OTf−, respectively (Fig. 12B and C).
oth complexes show ﬁve coordinate Fe(II) ions. However, while
iPrBIP)(SPh)(Cl) has the PhS− ligand in pseudoaxial position in
elation to the N3Cl− plane (Fig. 12B), the thiolate ligand is in a pseu-
oequatorial arrangement in (iPrBIP)(SPh)(OTf) (Fig. 12C). Notably,
nly the latter complex, which has the thiolate ligand in cis-position
o the open coordination site of Fe(II) afforded sulfur oxygenation
n the presence of O2 [65]. (iPrBIP)(SPh)(Cl), which has the thiolate
n trans position, by contrast formed an Fe(IV) O species andPhS−
ig. 12. Biomimetic complexes with the potential to oxygenate thiols. (A) The
e(II)(LN3S)(OTf)  complex (Fig. 12A, left) has the thiol group covalently linked
o  the chelating ligand and incubation with O2 leads to the sulfonate product.
y  analogy, (B) the non-covalently linked thiolate ligand in cis-position of com-
lex Fe(II)(iPrBIP)(SPh)(OTf) is oxygenated, while (C) for the analogous complex
e(II)(iPrBIP)(SPh)(Cl), which has the thiol ligand in trans position, iron oxygenation
o  Fe(IV) O is observed instead.e metal coordinated sulfur atom of the substrate, as proposed based on a crystal-
was concomitantly oxidized to the disulﬁde. It has also been shown
that a thiolate-ligand is crucial for the activation of the non-heme
bis(imino)pyridine complex by lowering the reduction potential.
These observations further support a mechanism that proceeds via
direct coordination of sulfur to the metal center and where the
relative positioning of the thiol moiety plays a critical role in deter-
mining, whether oxygenation occurs at the iron or sulfur.
2.2.2.  Diketone dioxygenase (Dke1)
2.2.2.1. Physiological role. Dke1 was  the ﬁrst committed enzyme
of the acetylacetone (acac) degradation pathway in Acinetobacter
johnsonii (DSMZ-ID: 98–849).2 The organism was  isolated from
sewage based on its ability to grow on acac as the sole source
of carbon [67]. Dke1 catalyzes the O2-dependent cleavage of acac
into methylglyoxal and acetate, which are then further metabo-
lized. Data mining indicates that the enzyme may  be widespread
among microorganisms from different sources, as highly similar
sequences were also isolated from the Sargasso sea during a shot-
gun sequencing project [68]. Furthermore, acac cleavage activity
has been demonstrated from a homologous Burkhoderia xenovorans
protein [69].
2.2.2.2.  Metal-center and active-site geometry. Dke1 is a functional
homotetramer composed of subunits of 153 amino acids in length.
The Dke1 structure shows a cupin fold and also displays the proto-
typical cupin metal binding motif. Notably, in the crystal structure
(PDB: 3BAL) [70], the conserved Glu69 residue of the cupin sig-
nature is not positioned in the active site and mutational analysis
conﬁrms that Glu69 is not required for metal binding or catalysis
[71]. By contrast, the substitution of the three histidine residues
His62, His64 and His104, which coordinate the metal ion in the
crystal structure (Fig. 13), leads to a marked decrease in Fe(II)
binding-afﬁnity and activity loss [72]. However, the crystal struc-
ture of Dke1 contains a Zn(II)-ion in the active site and very recent
molecular dynamic studies suggest that the Fe(II) containing struc-
ture indeed coordinates the metal cofactor via the 3 histidines and
Glu98. Upon substrate binding Glu98 is displaced and the catalyti-
cally competent complex forms a 3-His center, similar to the crystal
structure [73].
2 Deposition number of the bacterial strain at ‘Deutsche Stammsammlung für
Mikroorganismen  und Zellkulturen’.
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Fig. 13. 3-His metal center of Dke1 and hydrophilic active site residues, Tyr70,
Arg80,  Glu98 and Thr107 (PDB: 3BAL) [70]. The metal ion in the structure, which
is  Zn(II), is shown in orange, water molecules are in slate blue, oxygen atoms and
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Circular dichroism (CD) and MCD  spectroscopic studies of the 3-
is metal center of Dke1 have shown that the enzyme follows the
echanistic paradigm of O2 activation of the facial triad enzymes,
hich is outlined in Fig. 2. The resting enzyme Dke1 shows no
igniﬁcant difference in the 6-coordinate metal ion’s ligand ﬁeld
ompared to the facial triad enzyme CS2 and becomes a mixture of
- and 6-coordinate species upon binding of acac. DFT calculations
upport loss of water driven by binding of the strong donor acac,
hich decreases water afﬁnity by ∼2.8 kcal.mol−1. The binding of
he organic co-substrate -KG co-substrate dependent facial triad
nzymes (e.g. CS2) in general do not lead to a loss of water and it
as been argued that there, the facial triad’s prototypical carboxy-
ate ligand stabilizes the 6th water ligand via its non-coordinated
xygen. Thus organic co-substrate dependent facial triad enzymes
nsure that no decoupled oxygenation of the cofactor takes place
ntil the organic substrate is bound, which then induces a steric dis-
lacement of the 6th ligand.3 A comparison of Dke1 and the facial
riad enzyme 4-hydroxyphenylpyrvate dioxygenase, both chelated
ith acac, gives a generally similar geometric and electronic struc-
ure, however the metal-to-ligand charge transfer band of Dke1 is
hifted to higher energy by 1000 cm−1. This reﬂects the higher pos-
tive charge in the active site of the 3-His center of Dke1, which
ecreases the energy of the d manifold [74]. Combined kinetic
nd CD/MCD studies on the effect of pH on the Dke1 active site
howed a depressed pKa for bound water (∼8.2) at the 3-His cen-
er and that deprotonation of the water ligand negatively affects
he velocity of substrate binding to the metal center. A water-
ydroxide equilibrium at this pH range is not typically found for
acial triad mononuclear non-heme-Fe(II) sites and may  be a result
f the distinct net charge of the 3-His motif compared to its 2-His
-carboxylate counterpart [75].
.2.2.3. Reaction mechanism. Dke1 is strictly dependent on the
e(II) cofactor, although the catalytic Fe(II) site of Dke1 can be sub-
tituted by various other metal ions such as Fe(III), Co(II), Ni(II),
u(II), and Zn(II). Dke1 converts a wide variety of -diketone
3 Notably, in 4-hydroxyphenylpyruvate dioxygenase, which does not depend on
n organic co-substrate, the resting metal site is already partially 5 coordinate.hemistry Reviews 257 (2013) 541– 563
substrates capable of forming cis--keto-enolate structures [76].
According to 18O labeling studies, one atom of molecular oxygen
is incorporated into each acetylacetone cleavage product, namely
acetate and methylglyoxal. Consequently Dke1 has been classi-
ﬁed as a dioxygenase [77]. The enzymatic activity of Dke1 linearly
depends on the concentration of O2 up to 1.2 mM,  which is the
limit of O2 solubility under ambient conditions. The rate determin-
ing step has consequently a second order rate constant kcat/KmO2
of 35 s−1 mM−1 for acac under standard conditions. Enzyme activ-
ity varies by a factor of up to 105 as a function of the electronic
substrate structure and a combination of quantitative structure
activity relationship analysis and single-turnover kinetics revealed
that the energy of the highest occupied molecular orbital directly
correlates with the rate of O2 dependent cleavage of the respec-
tive chromogenic diketonate-Fe(II)-Dke1 complex. Based on these
observations it was concluded that O2 reduction is the rate deter-
mining step of the enzymatic reaction. The aromatic inhibitor
2′-hydroxyacetophenone lowers the redox potential to a degree
comparable to acac in inorganic Fe(II) complexes but it is energet-
ically prohibited from forming a C O bond with O2 as this would
compromise the ligand’s aromaticity. Therefore, it was suggested
that O2 reduction and C O bond formation cannot be kinetically
resolved and the rate determining step is the concerted oxidation
of acac to the respective C-3 centered peroxidate intermediate by
O2 [78]. The pattern of C C bond scission upon diketone conver-
sion strongly depends on electronic substituent effects in Dke1
with favorable C C bond cleavage adjacent to the more elec-
tron withdrawing group, indicating a negatively charged transition
state during C C bond ﬁssion. Consequently a peroxidate cleavage
mechanism via a dioxetane intermediate was  proposed (Fig. 14,
path1) [77].
Computational analysis: More recently the reaction mechanism
was revisited using QM calculations. The formation of a C-3 cen-
tered peroxidate intermediate was  substantiated and a preceding
Fe(III)-O•− intermediate that was  high in energy was found which
rationalizes why O2 reduction and C O bond formation cannot be
decoupled. According to computational analysis, the O O bond of
the peroxidate intermediate cleaves yielding a Fe(IV) = O species
and – as the oxygen distal to the iron attacks the dicarbonyl’s C2 – an
epoxide intermediate. The latter collapses into an ester compound,
which is then attacked via the Fe(IV) = O species and cleaved to the
ﬁnal products (Fig. 14, path 2) [79]. The C C bond cleavage step
proceeds via a negatively charged intermediate and is therefore in
line with the previously observed diketonate cleavage pattern [77].
2.2.2.4. The impact of outer shell residues on catalysis. Hydrophilic
outer shell residues have a signiﬁcant impact on the functionality
of the 3-His binding site, as demonstrated by mutational and
enzyme kinetic analyses [75]. Substitution of Thr107, an outer
shell residue which is in H-bonding distance of putative metal-
bound waters, leads to Fe(II) loss, presumably by destabilizing
water ligands (Fig. 13). Glu984, which is also located in the 2nd
shell of the metal center and hydrogen bonds with N2 of His104,
on the contrary, is not required for metal cofactor binding. It
stabilizes the 6-coordinate geometry of the metal center and
promotes ligand-exchange, thus accelerating substrate binding.
Upon its substitution the metal center of resting Dke1 becomes
partially 5-coordinate, whereby, notably, auto-oxidation rates are
not measurably increased. The three hydrophilic residues Glu98,
Arg80 and Tyr70, which form a hydrophilic gate to the active site
cavity and coordinate an outer shell water molecule (see Fig. 13),
are crucial for efﬁcient O2 reduction. Substitution by alanine
4 Note that very recent molecular dynamic studies suggest that Glu98 is a ﬁrst-
sphere ligand in resting Fe(II)-Dke1, vide supra [73].
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ically characterized, using a range of substituted diketonates (not
shown). Substituted hydrotris(pyrazol-1-yl)borate and the neutral
tris(2-phenylimidazol-4-yl)phosphine were employed as ligands
and a range of ﬁve-and six coordinated Fe(II) complexes wasig. 14. Reaction mechanism of diketone cleavage by Dke1. As the initially propose
n  energy, an alternative, energetically more feasible C C bond cleavage mechanism
nd – in the case of Glu98 – also glutamine leads to a ∼50–100-fold
ecrease in O2 reduction rates, while the structurally conservative
utation of Tyr70 to phenylalanine leads to a 3-fold decrease of the
atalytic rate. It has been proposed that the hydrophilic gate may
tabilize the transition state by providing a hydrogen bond that
tabilizes the negative charge on the evolving superoxide species
r, alternatively, that it promotes the O2-reactive 5-coordinate
pecies by limiting water access to the active site.
.2.2.5. Substrate-promiscuity of Dke1. The 3-His center of Dke1
as been probed for enzymatic activity towards substrates of other
rototypical non-heme-Fe(II) enzymes [80]. Notably, low catechol
xtradiol-cleavage activity was observed, which demonstrates
he principle potential of the 3-His center to perform a facial
riad-type reaction. Also, substantial reactivity towards maltol
as found and kinetically characterized. Maltol can be viewed as
 truncated quercetin-substructure. Maltol cleavage was  strictly
e(II) dependent, and no reactivity was observed for Dke1 variants
hat had been substituted by Cu(II), Mn(II), Zn(II), Co(II) or Ni(II).
otably, phenylpyruvate and 4-hydroxyphenylpyruvate were
xygenatively cleaved at the C2-C3 bond in Dke1. In contrast,
-hydroxyphenylpyruvate converting dioxygenases are facial triad
nzymes that decarboxylate their substrate similar to the -KG
ependent dioxygenases. Substrate binding was subsequently fur-
her characterized spectroscopically via low temperature CD/MCD
nd resonance Raman spectroscopy and it was  found that the
eviating reactivity stems from a distinct binding mode. While the
-oxo-acids are generally bound in their mono-anionic form in
he facial triad employing oxygenases, 4-hydroxyphenylpyruvate
as  coordinated in its di-anionic form, as an enolate, at the 3-His
enter of Dke1 [79]. DFT calculations have shown that enzymatic
onversion of the di-anionic form proceeds via a Fe(III)-HPP•-O22−
pecies, which rearranges to a Fe(IV) O-epoxide and is then
leaved to benzaldehyde and oxalate, while mono-anionic binding
t the 2-His-1-carboxylate center initiates the prototypical keto-
cid dioxygenase mechanism.5 The distinct cleavage pattern at
he 3-His-Fe(II) center compared to the 2-His-1-carboxylate site
5 Note that by analogy two distinct cleavage patterns for phenylpyruvate have
reviously  been reported for oxygenative cleavage of phenylpyruvate in mono- and
inuclear Fe(II) complexes, which apparently showed distinct substrate-ionizations
81].tion mechanism via a dioxetane intermediate (path 1, dashed arrows) [77] is high
been proposed based on DFT calculations (path 2) [79].
suggests that one role of the metal binding motif is to stabilize the
correct ionization state in the metal bound (co)substrate molecule.
2.2.2.6. Biomimetic complexes. A bio-mimetic Fe(II) complex was
synthesized, using hydridotris(3,5-dimethylpyrazol-1-yl)borate as
a  chelating ligand and diethyl 3-phenylmalonate as the -
diketonate ligand and a functional model for O2 dependent
diketone cleavage by Dke1 was obtained (Fig. 15) [82]. Notably,
the native substrate of Dke1, acac, was not cleaved in an analogous
complex. Incorporation of one atom of molecular oxygen into each
cleavage product, ethyl benzoylformate and CO2 was  conﬁrmed
by 18O labeling studies. The authors have proposed that the acti-
vated primary superoxo-species performs an attack on C-2 of acac
in Dke1. This mechanism is, however, not supported by DFT cal-
culations (vide supra). More recently, a series of high-spin iron(II)-
-diketonato complexes has been spectroscopically and electron-Fig. 15. Structural representation of an Fe(II) complex mimicking -dicarbonyl
cleavage.  Hydridotris(3,5-dimethylpyrazol-1-yl)borate is the chelating ligand and
diethyl 3-phenylmalonate is the -dicarbonyl ligand, which undergoes cleavage in
the presence of O2.
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btained [83]. The inorganic complexes showed comparable elec-
ronic properties as the analogous complexes of Dke1 with the var-
ous substituted diketonates [78]. Studies regarding the reactivity
f these biomimetic complexes towards O2 are not published so far.
.2.3. 3-His coordinated aromatic ring-cleaving dioxygenases
Ring-ﬁssion dioxygenases are key-enzymes for the aerobic
egradation of aromatic structures. Fe(III) intradiol-cleavage cat-
chol dioxygenases break the ring’s C C bond between the two
eminal hydroxyl-groups, while their counterparts, the extra-
iol cleavage dioxygenases depend on Fe(II) and cleave the
ond in the 2,3 position of the 1,2-catechol structure [84,85].
he latter have the common 2-His-1-carboxylate coordinated
e(II) center [6]. A third group of dioxygenases cleaves aromatic
tructures that do not contain geminal diols. These enzymes gen-
rally show a bicupin structure, i.e. the protein folds into two
upin domains [10]. Among these enzymes are the dioxygenases
hat convert 3-hydroxy-anthranilate [86], homogentisate [87], 2-
minophenol [88], 5-amino-salicylate [89], 5-nitro-salicylate [90],
-chloro-salicylate [91], gentisate [92], salicylate [93], and 1-
ydroxy-2-naphthoate [94]. The latter four conversions take place
ig. 16. Ring cleavage reactions of the facial triad enzymes (A) homogentisate dioxygena
oordinated counterparts (C) gentisate dioxygenase (GDO), (D) 1-hydroxy 2-naphthoate d
,2-dioxygenase (CGDO).hemistry Reviews 257 (2013) 541– 563
at an enzymatic 3-His coordinated Fe(II) center, while the ﬁrst two
substrates are cleaved by enzymes that display the ‘classical’ 2-
His-1-carboxylate binding signature. The other enzymes are not
structurally characterized. Reactions catalyzed by the third group-
ing of dioxygenases are shown in Fig. 16.
2.2.3.1. Gentisate 1,2-dioxygenase (GDO). GDO cleaves the C1 C2
bond of gentisate and a broad range of 3- and 4-substituted sub-
strate analogues – among them alkyl- and halogen substituted
structures – by concomitant incorporation of molecular oxygen
[95,96]. Biochemical studies have established that ferrous iron is
the catalytically competent metal cofactor [95,97,98]. EPR stud-
ies of GDO complexes with the O2-surrogate NO showed an S = 3/2
species for resting enzyme and upon substrate binding the signal
was signiﬁcantly perturbed [97]. When performed in H217O the
signal of resting enzyme was signiﬁcantly broadened, while sub-
strate binding led to a line sharpening. It was suggested that this is
due to replacement of water ligands from the active site. Further-
more, when 17O labeled gentisate analogues were used as ligands,
signal broadening was  again observed for labeled carboxylate- and
2-OH substituents, but not for the 5-OH substituent, suggesting that
se (HGDO) and (B) 3-hydroxyanthranilate 3,4-dioxygenase (HADO) and their 3-His
ioxygenase (HNDO), (E) salicylate 1,2-dioxygenase (SDO) and (F) 5-chloro-gentisate
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tive outer shell residues that are suggested to assist in catalysis are
shown in Fig. 18.ig. 17. Proposed gentisate cleavage mechanism, adapted from references [97,101
lectron transfer from Fe(II), followed by attack of the activated oxygen species at C2
nd  metal coordinated water molecules as well as outer shell residues that assist in
entisate chelates the Fe(II) cofactor via the carboxylate and the
djacent hydroxy moieties. Consequently a reaction mechanism
as been suggested where coordination of the electron donating
ubstrate lowers the redox-potential so that Fe(II) can activate O2
y transfer of an electron for attack of the aromatic ring. The ring
hows a positive partial charge at C2 due to charge delocalization
etween the substrate and metal. Subsequent heterolytic cleavage
f the peroxidate intermediate and Criegee rearrangement would
ead to incorporation of one atom of oxygen. Hydrolysis of the
esulting ester bond leads to the ﬁnal product. The mechanism is
utlined in Fig. 17. In this mechanism the redox-active metal acts
s an electron conduit. Note that more recent quantum-mechanic
tudies have shed further light on the reaction pathway (vide infra
nd Fig. 20) [99].
The  crystal structures of GDO from E. coli O157:H7 (PDB: 2D40)
100] and from Silicibacter pomeroyi (PDB: 3BU7) have been solved
101]. The active sites are superimposable and structures show
he metal binding site in the N-terminal cupin domains, which
re oriented outwards in the tetrameric structure and thus readily
ccessible for substrate.6 The iron cofactor is coordinated by the -
itrogen atoms of the three histidine residues (His119, His121, and
is160 in Silicibacter GDO) and one water molecule. The enzymes
ere crystallized aerobically and Fe may  be present as Fe(III), butit
s modeled with Fe(II) in the S. pomeroy structure. E. coli GDO was
trongly inhibited by Cu(II), Zn(II) and Mn(II) [100]. The glutamate
oiety in the conserved cupin motif is substituted by an alanine
n GDOs, thus presumably providing space for bidentate binding of
he substrate and allowing for the sixth coordination site to be free
or O2 coordination. It has been suggested that the mechanism is
upported by acid–base catalysis [100] and, based on in silico dock-
ng studies, it has been proposed that His162 acts as proton donor
6 In the S. pomeroyi structure, the C-terminal cupin domain also has a homologous
etal-binding  site. principle mechanism of Harpel and coworkers suggest initial activation of O2 by
e substrate, resulting in the peroxidate intermediate. The 3-His metal binding motif
ysis are inferred based on the crystal structure [100,101].
to the evolving peroxidate intermediate (Fig. 17), while the dyad
of Asp175 and Gln108 (numbering based on the S. pomeroy GDO
structure) assists in deprotonation of the 5-hydroxyphenyl group
(Fig. 17) [101]. The metal center of S. pomeroy GDO with the respec-Fig. 18. Iron-center of GDO from S. pomeroy (PDB: 3BU7) in the N-terminal domain
of  the bicupin structure. The metal ion is coordinated by the metal binding residues
His119,  His121 and His160. Outer-shell residues Gln108, His162 and Asp175, which
have been suggested to partake in acid–base catalysis are also shown. Note that the
metal ion is presumably present in its ferric form in the crystal structure. Oxygen
atoms  and nitrogen atoms are shown in red and blue, respectively. Water molecules
are shown in slate blue. H-bonds are indicated as slate blue dashed lines. (For inter-
pretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of the article.)
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Fig. 19. Iron center and substrate binding pocket of SDO from P. salicylatoxidans in its (A) free (PDB: 2PHD) and (B) gentisate chelated (PDB: 3NL1) forms. Some residues
are omitted for clarity. Oxygen atoms and nitrogen atoms are shown in red and blue, respectively. The substrate ligand is in teal. Water molecules are shown in slate blue.
H-bonds are indicated as slate blue dashed lines. Note that substrate binding leads to a movement of the Met46 residue away from the substrate binding site, while Arg83
moves closer above the plane of the substrate ligand. Residues, Gln108, Asp174, His162, Arg127 Trp72 are repositioned due to substrate binding. Further note that residues
analogous to Gln108, Asp174, His162 have been suggested to promote acid–base catalysis in GDO. (For interpretation of the references to color in this ﬁgure legend, the
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.2.3.2. Salicylate 1,2-dioxygenase (SDO). SDO has been found in
 strain that is competent to degrade substituted naphthalene-
ulfonates, which are used as industrial detergents and building
locks. SDO from Pseudomonas salicylatoxidans BN12 has been
rystallized and shows the 3-His metal binding center in the N-
erminal cupin domain [102]. The fold of SDO is very similar to
he previously discussed GDO structures. The enzyme converts
entisate, 5-aminosalicylate, and 1-hydroxy-2-naphthoate with
arkedly higher activity than salicylate, whereby the ‘best’ sub-
trate gentisate is cleaved at >100-fold efﬁciency [93]. The enzyme
an furthermore convert a range of halogenated salicylates as well
s 3-amino- and 3- and 4-hydroxysalicylate [103]. The crystal struc-
ures of the anaerobic complexes of SDO with salicylate, gentisate
nd 1-hydroxy-2-naphthoate have been solved. Principle active site
rganizations of substrate-bound structures are rather similar and,
herefore, will be discussed regarding the gentisate chelated struc-
ure of SDO. The substrate bound structure (Fig. 19B) reveals – in
omparison with the free enzyme structure (Fig. 19A) – a struc-
ural rearrangement from an open to a closed form upon substrate
inding. Residues Gln108, His162 and Asp174, which correspond
o Gln108, His162 and Asp175 in GDO, have been implicated as
cid–base catalysts there. These residues reorient upon substrate
inding and form a H-bonding network with the substrate carboxy-
ate and with Arg127, which also repositions. Arg83 enters the 6 A˚
phere of the metal ion, which deﬁnes the active site, and also H-
onds to the ligand’s carboxylate moiety, while Met42 leaves the
ctive site and also Trp104 reorients.
The structures conﬁrm the previously suggested substrate bind-
ng mode in GDOs. There are some minor structural deviations
etween GDOs and SDOs and also between SDOs that have dif-
erent substrates bound, which will not be discussed in detail here.
ost noteworthy, Arg127 and His162 show a substantially differ-
nt orientation in GDOs and SDOs. Also, in the structures where
alicylate or 1-hydroxy-2-naphthoate are bound, which in contrast
o gentisate miss a substituent at position 5, the two  side chains
f Trp104 and Asp174 are involved in a hydrogen bonding net-
ork with one water molecule in the cavity, which is absent in the
ase of the structure that has gentisate bound (not shown). This
nteraction has been suggested to play a central role in substrate
ecognition and catalytic intermediate stabilization [104]. Asp174
s highly conserved in all known GDOs as well, while residue 104 is
 Tyr residue in most GDO sequences and a serine residue in NDO.
he latter cannot cleave gentisate or salicylate [94,105].2.2.3.3. Gentisate versus homogentisate dioxygenase mechanism.
Although showing a distinct metal binding motif, HGDO catalyzes
the analogous reaction to GDO and reactions are believed to
proceed via an analogous mechanistic pathway [97,106,107]. Gen-
erally, HGDO and GDO have strong overall structural similarity
[100,107] as they share the bicupin fold. Yet HGDO, which has the
active site located in the C-terminal cupin domain, employs the
facial 2-His-1-carboxylate triad for catalysis [107], while GDO and
SDO rely on the 3-His center.
It is not clear why such apparently similar catalysis depends
on distinct metal binding centers which are strongly conserved in
the respective classes of GDOs/SDOs and HGOs. When consider-
ing a putative role of the metal binding motif as a stabilizer of the
correct ionization state of the ligand, as proposed based on results
from Dke1 [78], a possible explanation may  lie in the co-evolution
of outer-shell residues. The substrate bound structures of SDOs and
GDOs and structural alignments suggest an interaction of aspartate,
histidine and, in the case of GDO, tyrosine residues with the sub-
strate/intermediate ligand. The presence of two  arginine residues in
the active site is demonstrated for SDO. For HGDO, by contrast, two
histidine residues and no other charged residues are found in the
free HDO crystal structure (no substrate bound structure is avail-
able). Titus and coworkers have suggested that His292 and His365
or a metal bound hydroxide may  help deprotonate the 5-hydroxy
and 2-hydroxy positions (Fig. 20). A reasonable hypothesis is that
these active site residues, together with the respective metal center
collaborate to keep the substrate ligand in the correct protonation
state. However, in light of the major structural rearrangements in
SDO upon substrate binding, structural data of substrate-bound
proteins will be required to further investigate this hypothesis.
Computational studies: More recent quantum-mechanic calcula-
tions of a strongly related, albeit 2-His-1-carboxylate-coordinated
system,  homogentisate 1,2-dioxygenase (HGDO), have suggested a
mechanism that is similar to the one proposed for GDO. Calculations
suggest that, indeed, formation of the peroxidate intermediate from
substrate and O2 proceeds without a net change of the metal ions
oxidation state. The transition state shows peroxo-character on the
dioxygen fragment, while the C1-bound phenolic group turns into
a ketone functionality and carbocation character is found at C2.
This is in good agreement with the proposed mechanism for GDO
(Fig. 17) [97]. However, it was found that a homolytic cleavage
of the superoxide’s O O bond is more likely to occur than het-
erolytic cleavage (previously suggested for the GDO mechanism),
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hich leads to an epoxide-radical intermediate and in several steps
nally to the product (Fig. 20). Note that the differences regarding
he depicted proposed pathways in Fig. 17 and 20 reﬂect differ-
nt suggested hypotheses and not an intrinsically different reaction
athway of HGDOs and GDOs).
.3. 3-His-1-carboxylate motif
.3.1. Quercetin 2,3-dioxygenase (QDO)
.3.1.1. Enzymology and metal ion promiscuity. QDOs are key
nzymes in the assimilation of the plant ﬂavonol quercetin and
elated structures and have ﬁrst been reported in Aspergillus strains
108], where they are excreted in order to decompose the nat-
ral compounds [109]. Beside fungal QDOs, also bacterial QDOs
ave been described since. QDOs are not strictly Fe(II) dependent
nd, indeed, Aspergillus dioxygenases have generally been consid-
red Cu(II) dependent [110,111], although alternate metal variants
f the enzyme have been reportedly active in metal replacement
tudies [111].
Bacterial QDOs show varying metal cofactor preferences. Bacil-
us subtilis QDO (BsQDO) produced in E. coli [112,113] has Fe(II)lculated in the presence of putative catalytic outer shell residues His365 and His292
bound.  Yet, reconstituted forms of BsQDO with Fe(III), Mn(II), Co(II),
Ni(II) or Cu(II) as a cofactor showed similar or higher activities
compared to their Fe(II) containing counterpart [114]. It was con-
sequently suggested that the Fe(II) content of recombinant BsQDO
may be due to heterologous expression conditions in E. coli. Based
on catalytic activities, Mn(II), which showed highest activity with
a turnover number of 25 s−1 was proposed as the native metal ion
[115]. A QDO from Streptomyces sp. FLA was  reported to prefer-
entially incorporate Ni(II) and Co(II) and had the highest turnover
number (40.1 s−1) with Ni(II) incorporated.
2.3.1.2. Structure and active-site geometry. Structures from
Aspergillus japonicus [116] and B. subtilis show that the Fe(II) form
of BsQDO is a homodimer composed of bicupin subunits with each
of the resulting four cupin domains binding a metal ion [114]. The
overall structure of Cu(II) QDO from A. japonicus resembles that
of BsQDO except that the fungal dioxygenase is glycosylated at
the dimer interface and only its N-terminal cupin is occupied by
a metal ion. Also, the substrate-binding site of BsQDO appears to
be more accessible to substrate with less bulky side chains. The
Fe(II) cofactor of BsQDO is penta-coordinate in each domain and
556 D. Buongiorno, G.D. Straganz / Coordination C
Fig. 21. Substrate bound metal center of Cu(II)-QDO from A. japonicus (PDB: 1H1I)
The ﬁrst coordination sphere is shown. Oxygen atoms and nitrogen atoms are shown
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18n red and blue, respectively. The substrate ligand is in teal. (For interpretation of
he references to color in this ﬁgure legend, the reader is referred to the web  version
f the article.)
as four protein ligands (3-His-1-Glu) derived from cupin motifs
 and 2, and one water ligand. The N- and C-terminal metal sites
how different geometries (not shown) however, namely a trigonal
ipyramidal geometry with a strongly bound glutamate moiety
2.1 A˚) in the N-terminus and a distorted tetrahedral geometry
ith the glutamate side chain positioned more remotely from the
etal center (2.4 A˚). Similar conformations (close and distant) of
he analogous Glu-moiety are found in fungal Cu(II) QDO.
A  substrate bound, anaerobic crystal structure is only available
or Cu(II)-QDO from A. japonicus and reveals a mono-dentate coor-
ination of quercetin to Cu(II) (Fig. 21).
The Glu ligand is in the ‘open’ conformation and positioned
uch that it can interact with the coordinating hydroxy group from
uercetin. It has been proposed that the Glu moiety holds the sub-
trate proton in place during catalysis and coordinates the metal ion
ia its carbonyl group [117]. The substrate shows some distortion,
hereby the C2 atom shows apparent sp3 hybridization suggest-
ng that this may  be due to stabilization of a cation centered radical
t C2 [117]. Notably, residues that stabilize the distorted structure
re not conserved in the B. subtilis structure, which implies that this
istortion may  not be crucial for catalysis. EPR studies, furthermore,
how a Cu(II) species and not a Cu(I)-substrate radical species, as
ay  be expected [118]. Also, Mn(II) and Co(II) oxidation states are
bserved upon quercetin binding according to EPR spectroscopy
115,119].
.3.1.3. Reaction mechanism. Aspergillus ﬂavus QDO incorporates
wo atoms of oxygen into the substrate upon cleavage with the
volving carbon monoxide remaining unlabeled, as demonstrated
y 18O incorporation studies [120]. Consequently, a reaction mech-
nism has been proposed where the C-3 of the quercetin structure
s oxidized by molecular oxygen to yield the respective peroxi-
ate (Fig. 22). Substrate cleavage may  then proceed via nucleophilic
ttack (pathway 1) or Criegee rearrangement (pathway 2) [111] of
he peroxidate moiety.
Based  on structural and EPR data two principle oxygenation
echanisms have been envisioned for QDOs, one that depends on
he redox-properties of the metal cofactor and one that does not. In
he latter case, O2 is reduced by the substrate, whereby the metal
on is not redox active but acts as a Lewis acid and enhances the
ntrinsic activity of the substrate by stabilizing its anionic form.
he analogous non-enzymatic oxygenative quercetin cleavage is
ong known [121]. A similar reaction is performed by the cofactor
ndependent 1-H-3-hydroxy-oxoquinaldine-2,4-dioxygenase and
-H-3-hydroxy-oxoquinoline 2,4-dioxygenase, two  enzymes that
rovide a stabilizing oxy-anion hole for generation of a substratehemistry Reviews 257 (2013) 541– 563
anion,  which acts as an electron donor for O2 reduction [122].
A comparable mechanism might very well explain the metal ion
promiscuity of QDO.
The  alternative mechanism involves electron transfer between
the metal ion and O2 and depends on the direct binding of O2 to the
metal cofactor. The coordination found in the crystal structure of A.
japonicus shows quercetin bound in a monodentate mode and thus
leaves – beside the 3-His-1-Glu metal binding motif – a vacant site
for O2 binding.
The  pronounced metal ion promiscuity of QDO, which can use
Fe(II), Fe(III), Mn(II), Ni(II), Co(II) and Cu(II) efﬁciently seems to be
hard to reconcile with the latter scenario. However, in the case of
the cofactor promiscuous 2,3-homoprotocatechuate dioxygenase
(2,3-HPCD), a facial triad enzyme, it was suggested that the metal
center may  act as an electron conduit [123]. Transient Mn(III) and
Fe(III) reaction-intermediates have been trapped and characterized
in 2,3-HPCD [124,125] indicating initial one-electron transfer from
the divalent metal center to O2. It has been argued that a strong
coupling of metal ion oxidation and subsequent reduction by the
substrate may  compensate for one another, so that the net rate of
these two steps could be similar for metal ions with distinct redox
potentials [123]. Very recently, Kumar and co-workers have suc-
cessfully used nitrosyl-hydride as an iso-electronic mimic for O2 in
the quercetin conversion by Mn(II)-BsQDO but not its Co(II)- and
Fe(II)-substituted counterparts [126] and it was therefore argued
that the described reaction proceeds via a metal mediated electron
transfer mechanism. Indeed, the two scenarios may not be mutu-
ally exclusive, and in cases such as Ni(II), where the alternative
redox state may  be hard to access, the cofactor’s mechanistic role
may actually be that of a Lewis acid. The proposed redox metal
dependent reaction mechanism is depicted in Fig. 22.
Computational analyses: DFT studies of Siegbahn demonstrate
that initial attack of copper by O2 is preferable to attack of substrate,
whereby a low lying excited state of the Cu(I) substrate-radical
species  ensures that the copper will remain in its divalent oxidation
state. The study furthermore suggests that a nucleophilic attack of
C1 by the peroxidate moiety (pathway 1, Fig. 22) is the energetically
preferred quercetin cleavage pathway [127].
2.3.1.4. Biomimetic complexes. Various potential mimics of the
QDO metal center can convert ﬂavonolate (ﬂa) in O2-dependent
reactions. Two  complexes appear to be particularly relevant
models for QDOs. (i) A complex of Cu(II) with 1,3-bis(2-
pyridylimino)isoindoline (ind) binds the organic ligand in its
deprotonated form and chelates the metal ion through three
nitrogen atoms. ﬂa coordinates through its keto- and eno-
late oxygen atoms in the complex, which crystallizes as
Cu(II)(ﬂa)(ind)··CH3CN (Fig. 23A) [128]. The geometry around Cu(II)
is described as trigonally distorted square pyramidal. The complex
is converted at temperatures >80 ◦C in the presence of O2 to 2-
benzoyloxybenzoate, in analogy to the reactivity of QDOs. Up  to
seven turnovers of the ﬂavonolate substrate could be achieved,
furnishing 2-benzoyloxybenzoate and its hydrolytic degradation
products. (ii) An Fe(III)-salen complexed with ﬂavolonate (Fig. 23B),
which has been crystallized, shows a distorted octahedral geome-
try around the Fe(III) center. Again, ﬂa is coordinated as a bidentate
ligand and the salen ligand shows a strongly twisted conformation.
The complex reacts with O2 at measurable rates only at elevated
temperatures (100–120 ◦C). However, in the presence of bulky car-
boxylate co-ligands reaction rates are dramatically increased, up
to 100 fold for a 10-fold excess of triphenylacetate. In the presence
of the carboxylate co-ligands, superoxide is formed during the O2
dependent conversion. O labeling studies conﬁrm that, in analogy
to quercetin conversion by QDOs, both atoms from molecular oxy-
gen are incorporated into the organic product, while CO remains
unlabeled. Consequently it has been suggested that the co-ligands
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Fig. 22. Proposed catalytic pathway of QDOs, consolidated from the mechanistic scenarios suggested for the Mn(II)/Fe(II) enzyme [115] and the Cu(II) enzyme [117]. Two
alternative cleavage mechanisms, a nucleophilic ring formation (red, pathway 1) and a Criegee rearrangement (green, pathway 2) are depicted. (The alternative redox-
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ause mono-dentate binding of the substrate and thus allow direct
nteraction of O2 and the metal cofactor and thus promote the reac-
ion, in accordance with the principle mechanism outlined in Fig. 22
129].
.3.2. Aci-reductone dioxygenase (ARD)
.3.2.1. Physiological signiﬁcance. Aci-reductone dioxygenase
ARD) has originally been reported as an enzyme of the methi-
nine salvage pathway in Klebsiella pneumoniae. This pathway
ecycles methionine from 5′-methylthioadenosine [130], which
s formed during the biosynthesis of polyamines or ethylene. In
rabidopsis thaliana it is an effector of the heteromeric G protein
 subunit and thus modulates cell division [131]. ARD cleaves
,2-dihydroxy-5-methylthiopent-1-en-3-one and analogous
ci-reductones in an O2 dependent reaction [132,133].
Fig. 23. Biomimetic complexes of QDO(A) Cu(II)(ﬂa)(ind) and  one step, is not shown.). (For interpretation of the references to color in this ﬁgure
2.3.2.2. Reaction mechanism and metal ion promiscuity. All available
mechanistic studies have focused on ARD from K. pneumoniae. The
most notable property of ARD from K. pneumoniae is its potential
to cleave the aci-reductone substrate via two  distinct pathways,
depending on the incorporated metal cofactor [134]. Fe(II) con-
taining ARD – and with reduced activity also Mg(II) substituted
ARD – produces the expected intermediates of the methionine
salvage cycle, formic acid and the corresponding oxo-acid (see
Fig. 24, reaction products of the upper cycle), while the Ni(II)- or
Co(II)-containing versions promote an off-pathway reaction which
yields carbon monoxide, formic acid, and the corresponding short-
ened acid (see Fig. 24, reaction products of the lower cycle). The
kinetic parameters of Ni(II)-ARD and Fe(II)-ARD are comparable,
with kcat values of 500 s−1 and 260 s−1, respectively, and KO2 and
KM-aci-reductone values of about 50 mM for both enzymes [133]. 18O
(B) Fe(III)(ﬂa)(salen) adapted from refs. [128] and [129].
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sotope labeling studies have demonstrated that both, the Ni(II) and
e(II) dependent pathways, proceed via complete incorporation of
olecular oxygen into each of the organic products, leaving carbon
onoxide unlabeled [132]. Ligand-binding experiments are con-
istent with an ordered mechanism in which the substrate binds
efore O2. UV spectroscopic studies suggest that substrate is bound
s a di-anion in both metallo-isoforms [133]. Spin-trapping exper-
ments with a cyclopropyl substituent bearing substrate analogue
s a suicide inhibitor have given inconclusive results.
A  mechanism has been proposed, where a single electron trans-
er from the metal bound di-anionic substrate to O2 is followed by a
ombination of the resulting radicals to form the peroxidate species
t C1 [135]. Given that the redox-inactive Mg(II) ion can readily sub-
titute for Fe(II) in ARD, no redox-active role of the metal cofactor
s proposed. The peroxidate species then performs a nucleophilic
ttack at the substrate’s C2 (Fe(II)-ARD) or C3 (Ni(II)-ARD), and after
lectro-cyclic reaction of the resulting four- or ﬁve-membered ring,
he respective reaction products result (Fig. 24). It has been sug-
ested that the role of the metal ion is to activate the respective
arbon for nucleophilic ring closure via Lewis acid interactions with
he coordinated oxygen moiety and consequently that differences
n substrate coordination geometries in Ni(II)-ARD and Fe(II) ARD
ay  determine the respective catalytic route [135].
.3.2.3. Enzyme- and metal-center structures of Fe(II)- and Ni(II)-
RD. ARD is a monocupin and the overall-structure of Ni(II) ARD
as determined by high-resolution NMR  [135,136]. It was later
eﬁned by using 13C,15N double quantum spectroscopy [137] and
y modeling of the backbone structure in the vicinity of the metal
on based on the crystal structure of mouse ARD (PDB: 1VR3), which
ad become available and shows 23% sequence identity with ARD
rom K. oxytoca.7 The Fe(II)-structure of ARD was solved indirectly,
7 Note that the identity of the metal ion cofactor of the mouse protein is not
nambiguously  determined.le) and Ni(II)-ARD (lower cycle), adapted from ref. [138].
via the His98→Ser ARD variant, in which the presumable metal
binding histidine residue is substituted by serine and no metal
cofactor is bound to the protein. The variant is more stable than its
wild-type Fe(II)-ARD and apo-ARD counterparts and shows a high
structural similarity to Fe(II)-ARD, as determined by comparison
of one- and two-dimensional 1H NMR  and 1H 15N heteronuclear
single quantum coherence (NSQC) spectra of Fe(II)-ARD and the
variant [138]. The structures suggest His96, His98, His140 and
Glu102 as the metal binding residues. However, as the struc-
ture surrounding the paramagnetic metal center (∼9 A˚ sphere)
cannot be determined directly via NMR  spectroscopy due to line
broadening, Ni(II) and Fe(II) coordination was probed via X-ray
absorption spectroscopy (XAS) [139,140]. For both, the Ni(II) and
Fe(II) containing resting ARD, octahedral coordination by N/O was
established with 3–4 coordinating histidines, and again, for both
isoforms it was  suggested based on XAS data that upon substrate
binding one histidine may  be replaced by water or another amino
acid. However, both enzyme variants are strikingly similar in their
metal center geometry albeit with somewhat distinct distances of
the nitrogen ligands, namely 2.18 A˚ for Ni(II) and 2.07 A˚ for Fe(II).
Site-directed mutagenesis of the proposed metal binding moieties
and of other conserved, putative alternative metal-binding residues
in ARD is also in line with His96, His98, Glu102, and His140 being
the metal binding residues in both ARD isoforms [140]. However,
the overall structures of Ni(II)- and Fe(II)-ARD differ signiﬁcantly
in their C-terminus, which even lead to distinct chromatographic
characteristics: In Ni(II)-ARD residues 158–164 form a tight turn,
placing Trp162 near the active site (∼7 A˚ distance from the metal
center), while in Fe(II)-ARD the last 22 residues (Asp157-Ala179)
are disordered, effectively opening the active site [138] (Fig. 25).
It  has been suggested that these structural differences may  arise
from the slightly different binding geometries or from a switch
from N to N binding of protein ligands at the metal center in
the two  ARD isoforms, which may  transmit the above described
perturbations. Note that both coordination modes, binding via N
and N, were equally possible with the Ni(II)-ARD model, whereas
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Fig. 25. Active site of (A) Fe(II)-ARD (PDB:1HJI) and (B) Ni(II)-ARD (PDB: 1ZZR). The 6 A˚ sphere surrounding the metal center of a representative NMR  structure from the
deposited data-set of NMR  structures is shown for each variant. Additionally, for Ni(II)-ARD C-terminal residues in the vicinity of the metal center (Asp157-Ile163) are shown
in  teal. Note that for the Fe(II)-ARD structure the N-terminus is disordered and hence not present in the deposited structure. Generally, the Ni(II) variant appears more tightly
packed around the metal center. Fe(II) is shown in orange, Ni(II) is depicted in green. Oxygen atoms and nitrogen atoms are shown in red and blue, respectively. Metal bound
waters have been omitted for clarity. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
F d base
o iously
m
s
e
c
a
d
b
s
O
enzymatic mechanism of Ni(II)-ARD [141–144]. One of theseig. 26. (A) Structure of the Ni(II) (2OH-1,3-Ph2PD)(6-Ph2TPA) complex as propose
f  the hexanickel enediolate cluster, which is the actual reactive species in the prev
odeling a N binding mode severely perturbed the Fe(II)-ARD
pecies. While Ju and co-workers stress that the NMR  enzyme mod-
ls in the vicinity of the metal cofactors should be used with some
aution, they point out the interesting possibility that the distinct
ctive site geometries of the structures very well rationalize the
istinct reactivities of Ni(II)- versus Fe(II)-ARD. In their substrate-
ound models, they demonstrate that in the Fe(II)-ARD form the
ubstrate can coordinate via its adjacent oxygen moieties O1 and
2 without steric restriction, while in the Ni(II)-enzyme the steric
Fig. 27. (A) -Carotene Structure and (B) (3R)-3-hydroxy-8′-apocarotenol cleavd on 1H NMR, electronic absorption and infrared spectroscopy [142]. (B) One layer
 described Ni(II)-ARD model [145].
interference  of Trp162 (Fig. 25) makes O1 and O3 binding sterically
more favorable.
2.3.2.4. Biomimetic complexes. A range of bioinorganic Ni(II)-
complexes have been characterized in order to study thecomplexes showed ARD-type activity and will be discussed here
in more detail. No crystal structure was available, but based
on 1H NMR, electronic absorption and infrared spectroscopy the
age by the structurally characterized AO from Synechocystis sp. PCC 6803.
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Fig. 28. 4-His metal binding site of AO (PDB: 2BIW) with bound substrate. Note that
the 15-15′ double bond of the apocarotenoid substrate displays cis-conﬁguration.
Oxygen  atoms and nitrogen atoms are shown in red and blue, respectively. An iron
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aound water molecule is shown in slate blue. The protein contains Fe(III) in the
ctive  site, which is shown in orange. (For interpretation of the references to color
n this ﬁgure legend, the reader is referred to the web  version of the article.)
ollowing structure of the biomimetic complex was  proposed: N,N-
is[(6-phenyl-2-pyridyl)methyl]-N-[(2-pyridyl)-methyl]amine
6-Ph2TPA) and the aci-reductone analogue 2-hydroxy-1,3-
iphenylpropanedione (2OH-1,3-Ph2PD) coordinate Ni(II) via the
our nitrogen atoms of 6-Ph2TPA and via the O1- and O3-moieties
f deprotonated (2OH-1,3-Ph2PD). The metal center shows octa-
edral geometry (Fig. 26A). Upon treatment with one equivalent of
ase and exposure to O2 the complex decomposed to one CO and
wo carboxylate products. 18O incorporation studies demonstrated
hat one atom of molecular oxygen was incorporated into each
arboxylate product, in accordance with the enzymatic mechanism
f Ni(II)-ARD [142]. Rather recently it was shown that the reactive
pecies in this conversion is a hexanickel enediolate cluster, which
as crystallized and forms upon displacement of the chelate ligand
-Ph2TPA [145]. Each hexanickel cluster consists of two layers of
i(II) centers with each layer having three pseudo-octahedral Ni(II)
ig. 29. Reaction mechanisms of CarO as proposed based on DFT calculations, adapted f
hown.  The lowest energy pathways found proceed via a dioxetane- (path 1) and an epo
epicted. Both reaction pathways have been calculated in the presence and absence of me
ddition  of O2 porceeds via one concerted step (path 1a*, dashed arrow).hemistry Reviews 257 (2013) 541– 563
centers.  The deprotonated central oxygen of the enediolate ligand
forms the linkage between the layers. Each Ni(II) is consequently
coordinated by ﬁve oxygen atoms from the enediolate ligands and
is capped with an oxygen atom from a coordinated methanol. One
layer of the complex is shown in Fig. 26B.
2.4. Apocarotenoid-15,15′-oxygenase (AO)
Carotenoids constitute a group of isoprenoid pigments and
are generally composed of a C40-polyene. Carotenoid oxygenases
(CarOs) are found in animals, plants, fungi and cyanobacteria
[146–150], where their cleavage products, apocarotenes, act as
physiologically active substances, e.g. as hormones and in sig-
naling pathways. CarOs cleave a range of carotenoids, which are
widely distributed in nature. By analogy, apocarotenoid oxygenases
convert apocarotenes to a range of biologically active metabo-
lites. CarOs and apocarotene dioxygenases are described as O2
and Fe(II)-dependent enzymes and in nature they generally cat-
alyze the double-bond cleavage of carotenoids and apocarotenes,
respectively. CarOs with different C-C bond cleavage preferences
have been described. -Carotene along with numbering is shown
in Fig. 27A. While -carotene cleavage dioxygenase I in animals
[151–153] and its analog in fungi [154,155] cleave the 15,15′
bond of -carotene to retinal, other CarOs have been reported to
regiospeciﬁcally cleave the 7,8 (7′8′) [156], 9,10 (9′10′) [157–159]
and 5,6 bonds [160] of carotenoids. Also, lignostilbene struc-
tures cleaving oxygenases, which are considered close relatives
of CarOs, have been described [161–164]. CarOs have been clas-
siﬁed as both, mono- and dioxygenases based on 18O incorporation
studies [165–167]. These studies are generally complicated by a
label exchange from the resulting aldehyde with the solvent and,
consequently, distinct reaction mechanisms involving epoxide- or
dioxetane-formation have been suggested (vide infra, Fig. 29).
So  far, only the structure of apocarotenoid oxygenase from the
cyanobacterium Synechocystis sp. PCC6803 [168] has been solved,
rom [169]. Only the catalytically relevant substructure of the polyene substrate is
xide-intermediate (path 2), respectively. The pathway in the presence of water is
tal-bound water, with similar results, however, in the absence of water the side on
tion C
a
1
p
d
m
m
b
r
i
n
a
a
e
e
F
m
m
i
f
h
f
r
c
m
n
F
i
c
t
w
d
d
m
(
f
3
n
f
p
B
d
o
u
e
d
F
w
e
e
w
s
t
t
K
a
t
t
t
t
CD. Buongiorno, G.D. Straganz / Coordina
n enzyme that cleaves (3R)-3-hydroxy-8′-apo--carotenol at its
5–15′ bond (Fig. 27B). Notably, the structure was solved in the
resence of substrate. The iron center is coordinated via four histi-
ine residues and shows octahedral geometry (Fig. 28).
The  apocarotenoid substrate does not coordinate directly to the
etal, and leaves one metal coordination site occupied by a water
olecule in the enzyme–substrate complex. It should, however,
e noted that the structure contains Fe(III) and no information
egarding the geometry of the catalytically competent Fe(II) center
s available. The substrate, which is located in a non-polar tun-
el, could only be ﬁtted into the electron density when the 13–14
nd 13′–14′ trans double bonds were changed to cis conformations
nd it has been proposed that this isomerization, which has an
stimated energetic cost of about 100 kJ mol−1, may  be sterically
nforced when the substrate collides with the oxygen ligands of
e(II) [168]. Based on the structure, it has been proposed that O2
ight coordinate in a side-on fashion, thus displacing both water
olecules upon formation of the ternary complex.
Computational analyses: A computational study gives insights
nto probable reaction pathways of AO and, by extension, CarOs,
or which very few experimental enzyme-mechanistic studies
ave been reported so far. In order to investigate the energetic
easibility of the proposed dioxygenase- and monooxygenase-type
eactions the respective pathways have been investigated by DFT
omputational analysis. The presence and absence of a water
olecule in the active site have both been considered, as it is
ot known whether it is present in the catalytically competent
e(II)-AO complex with substrate. Pathways which were energet-
cally most favorable are outlined in Fig. 29. While Borowski and
o-workers found a slight preference for the side-on mechanism in
he absence of water (Fig. 29, path 1a*), the energetic differences
ere small [169], suggesting that mechanisms might be distinct
epending on subtle structural differences in the active sites of
ifferent CarOs. It has been pointed out that in silico the dioxetane
echanism ensures high speciﬁcity, while the epoxide mechanism
Fig. 29, path 2), particularly in the absence of water, would allow
or concurring 13′,14′ cleavage.
.  Conclusion
The strong conservation of the atypical metal binding motifs
ecessary for the catalyzed reactions implies that the deviations
rom the ‘classical’ non-heme-Fe(II) binding site serve a particular
urpose in the respective catalytic pathways. For the 2-His-Fe(II)
inding Motif research of the past few years has impressively
emonstrated its rationale: the carboxylate ligand is abandoned in
rder to provide a site for Cl− coordination, which is subsequently
sed as a substrate for halogenation. This, however, comes at the
xpense of a stable Fe(II) center in the absence of the co-factor.
The  impact of the 3-His-Fe(II) Center on catalysis is less well
eﬁned. Research shows that the 3-His center provides a stable
e(II) binding site and for Dke1 it has been shown that it can very
ell adopt the ‘protective’ 6-coordinate geometry of the resting
nzyme in the absence of a stabilizing 1st sphere carboxylate moi-
ty. The unprecedented substrate binding mode and cleavage path-
ay for phenylpyruvate-type structures at the 3-His center of Dke1
uggest that the metal binding motif may  contribute to stabilizing
he substrate ligand in the correct ionization state. It is noteworthy
hat many facial triad enzymes, like catechol 2,3-dioxygenase or -
G dependent enzymes bind their (co)substrate, which can adopt
 mono-or di-anionic form, as a mono-anion. By contrast, for dike-
ones only the mono-anionic state is available upon coordination
o the metal cofactor and for CDO the deprotonation of the binding
hiol (pKa 8.0) and ammonium moieties (pKa 10.25) – an ioniza-
ion state that is generally assumed in QM and QM/MM  studies of
DO [62,63,170] – could be a requirement for efﬁcient catalysis.hemistry Reviews 257 (2013) 541– 563 561
For  these substrates the 3-His center may  be preferable, as it can
more efﬁciently promote ligand deprotonation than the facial triad.
A similar rationale may  be at work in GDO, however the question
remains why  HGDO adopts the facial triad coordinated metal center
for a rather similar reaction. The answer may  lie in the co-evolution
of outer-sphere residues, which generally seem of great impor-
tance in MNHE functionality. This may  also help explain why  at
least some catechol 2,3-dioxygenase activity is found at the 3-His-
Fe(II) center of Dke1. Beside stabilization of the substrate ligand in
the correct ionization state, clearly, the substitution of a carboxylate
by a histidine ligand will also impact the redox potential and conse-
quently, the primary step of oxygen activation. In Dke1, an apparent
decrease of the d-manifold compared to the facial triad coordinated
Fe(II) center was  observed [74]. Studies of biomimetic complexes of
nitric oxide reductase have recently demonstrated how a carboxy-
late ligand can tune the redox potential of the Fe(II)/Fe(III) couple
[171]. While a low redox potential will make the primary reduc-
tion of O2 more favorable, it may  at the same time increase the
risk of uncoupled iron oxidation. To understand how this impacts
the MNHEs’ ‘choice’ of a particular metal binding motif and to what
extent outer sphere residues may  counterbalance the impact of the
ﬁrst shell is still a challenging feat and will be crucial when it comes
to the design of MNHEs with new functions.
The 3-His-1-Carboxylate-Fe(II) Center is used by enzymes to con-
vert substrates that are intrinsically susceptible to oxidation, which
makes an outer sphere mechanism of electron transfer, that is with-
out direct involvement of the metal cofactor, a plausible possibility.
Also a considerable lack of metal speciﬁcity is in line with such a
mechanism, where the metal cofactor does not directly partake in
the reaction. However, a direct interaction of O2 and metal center
cannot be ruled out on these grounds, particularly for QDO. Indeed,
it has been suggested that considerable metal promiscuity may  be
rather common for dioxygenases that only change the metal ion’s
oxidation state by one charge during catalysis, as the net rate of
the metal ion oxidation by O2 and the subsequent reduction by the
substrate may  compensate one another [124].
Little is known about the function of the 4-His-Fe(II) Center in
carotene dioxygenase. As catalysis does not depend on direct sub-
strate binding, a logical function of the motif may be to shield
the active site from water that is not required for catalysis, thus
allowing O2 and substrate to react.
While nature has demonstrated the feasibility of modulating the
metal binding motif in MNHCs in order to tune catalysis, doing so in
the context of enzyme engineering is still a great challenge as vari-
ation of the metal binding motif typically leads to the destruction
of a high afﬁnity Fe(II) binding site. Also, requirements for proper
substrate binding and positioning are high. The development of
computational tools may  help to overcome these challenges in
order to fully exploit the catalytic potential of MNHEs.
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